RecruitingNot ApplicableNCT07330323

CARES : Customized Aftercare Report for Evaluated Skin Cancer Patients

Development and Evaluation of a Personalized Discharge Letter for Low-risk Skin Cancer Patients After Dermatological Screening.


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

150 participants

Start Date

May 20, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Current clinical practices often provide general verbal advice to low-risk patients, which may not sufficiently address individual concerns or offer actionable steps. Generic information on the internet can be overwhelming or unreliable, leading to confusion and unnecessary follow-up visits. This project introduces a tailored approach by combining evidence-based guidelines with personalized details about the patient's risk profile. The discharge letter bridges the gap between clinical expertise and patient understanding, offering clear, specific, and actionable advice that has been shown to improve health behaviors and outcomes in other contexts . The personalized discharge letters are generated using an AI agent trained on validated letters from the hospital's electronic health record system (KWS). Each letter is reviewed and approved by a physician before being provided to the patient, ensuring both accuracy and clinical relevance.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Personalized Discharge Letter, a behavioral approach called Personalized Discharge Letter + IntelliStudio, and others for people with low risk, management, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALVerbal information only

Verbal information only

BEHAVIORALPersonalized Discharge Letter

Personalized Discharge Letter: Tailored written information based on individual risk profile, skin type and consultation findings.

BEHAVIORALPersonalized Discharge Letter + IntelliStudio

Personalized Discharge Letter + IntelliStudio: Tailored written information plus digital visual support (e.g. annotated images, visual summaries).


Locations(1)

UZLeuven, Department of Dermatology

Leuven, Vlaams-Brabant, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07330323


Related Trials